Corporate America has sprung into action to help the people of India grapple with the devastating second wave in the Covid-19 pandemic. Here is a small sample of announcements from the last 24 hours: Air Products is allocating resources and assets from its operations around the world to support and maximize...
Mylan Enters Exclusive Distributor Agreement for India with Gilead Sciences
Mylan Pharmaceuticals Private Limited, the Indian subsidiary of Mylan Inc., has entered into an agreement with Gilead Sciences, under which it has been appointed the exclusive distributor of Sovaldi® (sofosbuvir 400mg tablets) and Harvoni®(ledipasvir 90mg/sofosbuvir 400 mg tablets) for the treatment of chronic hepatitis C, in India. Mylan expects to...